$43.91
0.140.32%
al cierre: -
$43.36
-0.55-1.25%
After hour: 9:29 AM EDT
GSK informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Analice el historial de beneficios de GSK utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
GSK | GSK | $1.29 | $1.26 | — | — | $10.42B | $11.20B | — | — | 10/29/2025 | |
GSK | GSK | $1.10 | $1.12 | $1.24 | 10.80% | $9.95B | $10.33B | $10.66B | 3.19% | 07/30/2025 | |
GSK | GSK | $1.09 | $1.04 | $1.13 | 8.65% | $9.34B | $7.46B | $9.46B | 26.82% | 04/30/2025 | |
GSK | GSK | $0.72 | $0.43 | $0.58 | 34.88% | $10.06B | $9.57B | $10.06B | 5.17% | 02/05/2025 | |
GSK | GSK | $1.27 | $1.23 | $1.29 | 4.88% | $10.27B | $10.78B | $10.42B | -3.36% | 10/30/2024 | |
GSK | GSK | $0.97 | $0.99 | $1.10 | 11.11% | $8.97B | $9.70B | $9.95B | 2.55% | 07/31/2024 | |
GSK | GSK | $0.90 | $0.91 | $1.09 | 20.11% | $8.44B | $8.92B | $9.34B | 4.69% | 05/01/2024 | |
GSK | GSK | $0.61 | $0.75 | $0.72 | -4.27% | $8.65B | $9.61B | $10.06B | 4.73% | 01/31/2024 | |
GSK | GSK | $1.11 | $1.07 | $1.27 | 18.69% | $9.24B | $9.37B | $10.27B | 9.55% | 11/01/2023 | |
GSK | GSK | $0.87 | $0.87 | $0.97 | 11.49% | $8.72B | $8.97B | $8.97B | 0.03% | 07/26/2023 | |
GSK | GSK | $32.30 | $0.82 | $0.90 | 9.76% | $7.19B | $8.06B | $8.44B | 4.75% | 04/26/2023 | |
GSK | GSK | $0.86 | $0.50 | $0.61 | 22.00% | $12.84B | $8.91B | $8.65B | -2.90% | 02/01/2023 | |
GSK | GSK | $0.37 | $0.96 | $1.11 | 15.62% | $6.63B | $8.26B | $9.24B | 11.84% | 11/02/2022 | |
GSK | GSK | $0.99 | $0.89 | $0.87 | -2.25% | $11.33B | $9.17B | $8.72B | -4.95% | 07/27/2022 | |
GSK | GSK | $0.79 | $0.95 | $1.10 | 15.79% | $10.24B | $11.70B | $13.13B | 12.19% | 04/27/2022 | |
GSK | GSK | $0.78 | $0.81 | $0.86 | 6.17% | $11.62B | $12.79B | $12.84B | 0.39% | 02/09/2022 | |
GSK | GSK | $1.15 | $1.01 | $1.26 | 24.75% | $11.24B | $11.88B | $12.44B | 4.67% | 10/27/2021 | |
GSK | GSK | $0.60 | $0.71 | $0.99 | 39.44% | $9.46B | $10.54B | $11.33B | 7.49% | 07/28/2021 | |
GSK | GSK | $1.21 | $0.76 | $0.79 | 3.95% | $11.64B | $11.06B | $10.24B | -7.44% | 04/28/2021 | |
GSK | GSK | $0.80 | $0.80 | $0.78 | -2.50% | $11.84B | $11.60B | $11.62B | 0.20% | 02/03/2021 | |
GSK | GSK | $1.19 | $1.09 | $1.15 | 5.50% | $11.54B | $11.67B | $11.24B | -3.68% | 10/28/2020 |
Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
---|---|---|---|---|
Q2 | 2025-07-30 | $1.24 | $1.12 | 10.8 % |
Q1 | 2025-04-30 | $1.13 | $1.04 | 8.65 % |
Q4 | 2025-02-05 | $0.58 | $0.43 | 34.9 % |
Q3 | 2024-10-30 | $1.29 | $1.23 | 4.88 % |
Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
---|---|---|---|---|
Q2 | 2025-07-30 | $10.66B | $10.33B | 3.19 % |
Q1 | 2025-04-30 | $9.46B | $7.46B | 26.8 % |
Q4 | 2025-02-05 | $10.07B | $9.57B | 5.17 % |
Q3 | 2024-10-30 | $10.42B | $10.78B | -3.36 % |
Está previsto que GSK (GSK) presente resultados el octubre 29, 2025. Los últimos resultados se publicaron el julio 30, 2025 para el Q2.
El BPA real fue de $1.24, que superó la estimación de $1.12.
Los ingresos reales fueron $10.7B, que superó la estimación de $10.3B.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.